The necessity for transplantation of living cells from other species, or xenotransplantation, may arise when human donors are not available, a bridge organ is needed, or animal cells can provide a unique benefit to patients. Host Dr. Aaron Carroll's guests are xenotransplantation experts Dr. Paul Helft, director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health, and Dr. Joseph Tector, chief of transplant surgery at Indiana University School of Medicine. What is the history of xenotransplantation? What donor species are currently the subject of the most promising research in terms of solid organ transplantation and overcoming immunologic barriers and infection? Find out which patients might be the first to benefit.
Xenotransplantation: History and Current Advances Part 1 of 2

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The necessity for transplantation of living cells from other species, or xenotransplantation, may arise when human donors are not available, a bridge organ is needed, or animal cells can provide a unique benefit to patients. Host Dr. Aaron Carroll's guests are xenotransplantation experts Dr. Paul Helft, director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health, and Dr. Joseph Tector, chief of transplant surgery at Indiana University School of Medicine. What is the history of xenotransplantation? What donor species are currently the subject of the most promising research in terms of solid organ transplantation and overcoming immunologic barriers and infection? Find out which patients might be the first to benefit.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Level Up Your Skills: Tailoring Management of HF
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?